Peptides for activation and inhibition of δPKC
US8822636B2 · kind B2 · utility
0Cited by
10References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 30, 2010 |
| Grant date | Sep 2, 2014 |
| Priority date | — |
| Expiry date | Nov 30, 2030 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Peptides able to inhibit or activate the translocation or function of δPKC are identified. Administration of the peptides for protection or enhancement of cell damage due to ischemia is described. Therapeutic methods to reduce damage to cells or to enhance damage to cells due to ischemia are also described, as well as methods for screening test compounds for δPKC-selective agonists and antagonists.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.